MMP8
Basic information
Region (hg38): 11:102711796-102727050
Previous symbols: [ "CLG1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MMP8 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 27 | 37 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 2 | 3 | |||
non coding | 0 | |||||
Total | 0 | 0 | 27 | 8 | 8 |
Variants in MMP8
This is a list of pathogenic ClinVar variants found in the MMP8 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-102713365-T-C | Benign (Jul 15, 2018) | |||
11-102713404-G-A | not specified | Likely benign (Mar 28, 2016) | ||
11-102713423-G-A | Benign (Jun 18, 2018) | |||
11-102713855-T-C | not specified | Uncertain significance (Jan 31, 2024) | ||
11-102714626-C-T | not specified | Uncertain significance (Sep 20, 2023) | ||
11-102714628-C-T | not specified | Uncertain significance (Nov 04, 2022) | ||
11-102714650-A-T | not specified | Uncertain significance (Feb 15, 2023) | ||
11-102714682-T-C | not specified | Uncertain significance (Sep 22, 2022) | ||
11-102714705-G-A | Likely benign (Apr 01, 2022) | |||
11-102715331-C-A | not specified | Uncertain significance (Mar 24, 2023) | ||
11-102715360-G-A | not specified | Uncertain significance (Nov 09, 2021) | ||
11-102715411-A-G | Likely benign (Aug 01, 2023) | |||
11-102715432-A-G | not specified | Uncertain significance (Dec 01, 2022) | ||
11-102715440-A-G | Benign (Jun 05, 2018) | |||
11-102715443-G-A | Benign (May 20, 2018) | |||
11-102716306-C-T | Likely benign (Jun 13, 2018) | |||
11-102716330-G-A | not specified | Uncertain significance (Mar 11, 2022) | ||
11-102716336-T-C | not specified | Uncertain significance (Oct 05, 2022) | ||
11-102716423-G-A | Likely benign (Apr 17, 2018) | |||
11-102718435-C-T | not specified | Likely benign (Aug 04, 2021) | ||
11-102718474-T-C | not specified | Uncertain significance (Feb 06, 2024) | ||
11-102718507-G-A | not specified | Uncertain significance (Apr 26, 2023) | ||
11-102718519-G-A | not specified | Uncertain significance (Jan 30, 2024) | ||
11-102718547-A-G | Likely benign (May 30, 2018) | |||
11-102718547-A-T | not specified | Uncertain significance (May 06, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MMP8 | protein_coding | protein_coding | ENST00000236826 | 10 | 15256 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.07e-24 | 0.0000191 | 125459 | 1 | 286 | 125746 | 0.00114 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.613 | 277 | 250 | 1.11 | 0.0000123 | 3086 |
Missense in Polyphen | 116 | 102.38 | 1.1331 | 1268 | ||
Synonymous | -1.70 | 110 | 89.5 | 1.23 | 0.00000477 | 857 |
Loss of Function | -1.49 | 32 | 24.1 | 1.33 | 0.00000127 | 271 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00402 | 0.00391 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00152 | 0.00152 |
Finnish | 0.0000468 | 0.0000462 |
European (Non-Finnish) | 0.00137 | 0.00133 |
Middle Eastern | 0.00152 | 0.00152 |
South Asian | 0.000364 | 0.000359 |
Other | 0.00221 | 0.00212 |
dbNSFP
Source:
- Function
- FUNCTION: Can degrade fibrillar type I, II, and III collagens.;
- Pathway
- Matrix Metalloproteinases;Neutrophil degranulation;Collagen degradation;Extracellular matrix organization;Innate Immune System;Immune System;Degradation of the extracellular matrix
(Consensus)
Recessive Scores
- pRec
- 0.283
Intolerance Scores
- loftool
- 0.938
- rvis_EVS
- 1.58
- rvis_percentile_EVS
- 95.75
Haploinsufficiency Scores
- pHI
- 0.132
- hipred
- N
- hipred_score
- 0.133
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.630
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mmp8
- Phenotype
- homeostasis/metabolism phenotype; neoplasm; immune system phenotype;
Gene ontology
- Biological process
- proteolysis;positive regulation of gene expression;negative regulation of gene expression;extracellular matrix disassembly;extracellular matrix organization;collagen catabolic process;negative regulation of interleukin-10 production;positive regulation of interleukin-6 production;endodermal cell differentiation;neutrophil degranulation;positive regulation of DNA binding;positive regulation of MAPK cascade;positive regulation of nitric oxide biosynthetic process;positive regulation of JNK cascade;regulation of neuroinflammatory response;positive regulation of neuroinflammatory response;positive regulation of NIK/NF-kappaB signaling;positive regulation of reactive oxygen species biosynthetic process;regulation of microglial cell activation;positive regulation of microglial cell activation;positive regulation of tumor necrosis factor secretion
- Cellular component
- extracellular region;extracellular space;specific granule lumen;collagen-containing extracellular matrix;tertiary granule lumen
- Molecular function
- endopeptidase activity;metalloendopeptidase activity;serine-type endopeptidase activity;zinc ion binding